Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-670
Closed -$221K 130
2025
Q2
$221K Buy
670
+3
+0.4% +$967 0.09% 119
2025
Q1
$219K Buy
+667
New +$201K 0.09% 120
2024
Q4
Sell
-660
Closed -$229K 121
2024
Q3
$229K Sell
660
-1
-0.2% -$344 0.1% 114
2024
Q2
$219K Buy
661
+1
+0.2% +$345 0.1% 115
2024
Q1
$240K Buy
+660
New +$217K 0.11% 118
2023
Q1
Sell
-6,225
Closed -$2.06M 110
2022
Q4
$2.06M Buy
6,225
+419
+7% +$133K 0.91% 32
2022
Q3
$1.61M Buy
+5,806
New +$1.63M 0.86% 38

Other funds holding CI

G&S Capital's CI Position: Q3 2025 in Review

G&S Capital sold out of Cigna (CI) in Q3 2025, closing a stake of 670 shares — an estimated $221K sold.

G&S Capital first reported a position in CI in Q3 2022 and held it in 7 quarters. The position peaked at $2.06M in Q4 2022. 1,618 funds tracked by Wall St. Rank hold CI as of Q3 2025.

  • G&S Capital reported no remaining Cigna position as of Q3 2025 after selling out during the quarter.
  • G&S Capital sold 670 Cigna shares in Q3 2025, an estimated $221K.
  • G&S Capital first reported a position in Cigna in Q3 2022 and held it in 7 quarters.
  • G&S Capital's Cigna position peaked at $2.06M in Q4 2022.
  • 1,618 funds tracked by Wall St. Rank held Cigna as of Q3 2025.

Based on G&S Capital's 13F filing for Q3 2025, filed 23 Oct 2025.